nodes	percent_of_prediction	percent_of_DWPC	metapath
Oritavancin—Infusion site reaction—Pamidronate—Paget's disease of bone	0.0818	0.0818	CcSEcCtD
Oritavancin—Osteomyelitis—Alendronate—Paget's disease of bone	0.0792	0.0792	CcSEcCtD
Oritavancin—Infusion site reaction—Zoledronate—Paget's disease of bone	0.0747	0.0747	CcSEcCtD
Oritavancin—Osteomyelitis—Pamidronate—Paget's disease of bone	0.0604	0.0604	CcSEcCtD
Oritavancin—Osteomyelitis—Zoledronate—Paget's disease of bone	0.0552	0.0552	CcSEcCtD
Oritavancin—Induration—Pamidronate—Paget's disease of bone	0.0283	0.0283	CcSEcCtD
Oritavancin—Induration—Zoledronate—Paget's disease of bone	0.0259	0.0259	CcSEcCtD
Oritavancin—Myalgia—Tiludronate—Paget's disease of bone	0.0151	0.0151	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Tiludronate—Paget's disease of bone	0.0132	0.0132	CcSEcCtD
Oritavancin—Diarrhoea—Tiludronate—Paget's disease of bone	0.00993	0.00993	CcSEcCtD
Oritavancin—Dizziness—Tiludronate—Paget's disease of bone	0.00959	0.00959	CcSEcCtD
Oritavancin—Erythema multiforme—Etidronic acid—Paget's disease of bone	0.00925	0.00925	CcSEcCtD
Oritavancin—Headache—Tiludronate—Paget's disease of bone	0.00909	0.00909	CcSEcCtD
Oritavancin—Nausea—Tiludronate—Paget's disease of bone	0.00862	0.00862	CcSEcCtD
Oritavancin—Oedema peripheral—Alendronate—Paget's disease of bone	0.00821	0.00821	CcSEcCtD
Oritavancin—Erythema multiforme—Alendronate—Paget's disease of bone	0.00788	0.00788	CcSEcCtD
Oritavancin—Anaemia—Etidronic acid—Paget's disease of bone	0.00787	0.00787	CcSEcCtD
Oritavancin—Bronchospasm—Pamidronate—Paget's disease of bone	0.00781	0.00781	CcSEcCtD
Oritavancin—Angioedema—Etidronic acid—Paget's disease of bone	0.00778	0.00778	CcSEcCtD
Oritavancin—Infestation NOS—Risedronate—Paget's disease of bone	0.00745	0.00745	CcSEcCtD
Oritavancin—Infestation—Risedronate—Paget's disease of bone	0.00745	0.00745	CcSEcCtD
Oritavancin—Bronchospasm—Zoledronate—Paget's disease of bone	0.00713	0.00713	CcSEcCtD
Oritavancin—Infestation NOS—Pamidronate—Paget's disease of bone	0.00708	0.00708	CcSEcCtD
Oritavancin—Infestation—Pamidronate—Paget's disease of bone	0.00708	0.00708	CcSEcCtD
Oritavancin—Infection—Etidronic acid—Paget's disease of bone	0.0069	0.0069	CcSEcCtD
Oritavancin—Anaemia—Alendronate—Paget's disease of bone	0.0067	0.0067	CcSEcCtD
Oritavancin—Angioedema—Alendronate—Paget's disease of bone	0.00663	0.00663	CcSEcCtD
Oritavancin—Oedema peripheral—Risedronate—Paget's disease of bone	0.00659	0.00659	CcSEcCtD
Oritavancin—Connective tissue disorder—Risedronate—Paget's disease of bone	0.00657	0.00657	CcSEcCtD
Oritavancin—Infestation NOS—Zoledronate—Paget's disease of bone	0.00647	0.00647	CcSEcCtD
Oritavancin—Infestation—Zoledronate—Paget's disease of bone	0.00647	0.00647	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Etidronic acid—Paget's disease of bone	0.00633	0.00633	CcSEcCtD
Oritavancin—Connective tissue disorder—Pamidronate—Paget's disease of bone	0.00625	0.00625	CcSEcCtD
Oritavancin—Cardiac disorder—Risedronate—Paget's disease of bone	0.00621	0.00621	CcSEcCtD
Oritavancin—Myalgia—Alendronate—Paget's disease of bone	0.00618	0.00618	CcSEcCtD
Oritavancin—Immune system disorder—Risedronate—Paget's disease of bone	0.00604	0.00604	CcSEcCtD
Oritavancin—Mediastinal disorder—Risedronate—Paget's disease of bone	0.00603	0.00603	CcSEcCtD
Oritavancin—Cardiac disorder—Pamidronate—Paget's disease of bone	0.0059	0.0059	CcSEcCtD
Oritavancin—Infection—Alendronate—Paget's disease of bone	0.00588	0.00588	CcSEcCtD
Oritavancin—Malnutrition—Risedronate—Paget's disease of bone	0.00582	0.00582	CcSEcCtD
Oritavancin—Immune system disorder—Pamidronate—Paget's disease of bone	0.00574	0.00574	CcSEcCtD
Oritavancin—Mediastinal disorder—Pamidronate—Paget's disease of bone	0.00573	0.00573	CcSEcCtD
Oritavancin—Oedema peripheral—Zoledronate—Paget's disease of bone	0.00572	0.00572	CcSEcCtD
Oritavancin—Connective tissue disorder—Zoledronate—Paget's disease of bone	0.00571	0.00571	CcSEcCtD
Oritavancin—Malnutrition—Pamidronate—Paget's disease of bone	0.00553	0.00553	CcSEcCtD
Oritavancin—Urticaria—Etidronic acid—Paget's disease of bone	0.00552	0.00552	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Alendronate—Paget's disease of bone	0.00539	0.00539	CcSEcCtD
Oritavancin—Cardiac disorder—Zoledronate—Paget's disease of bone	0.00539	0.00539	CcSEcCtD
Oritavancin—Anaemia—Risedronate—Paget's disease of bone	0.00538	0.00538	CcSEcCtD
Oritavancin—Angioedema—Risedronate—Paget's disease of bone	0.00532	0.00532	CcSEcCtD
Oritavancin—Immune system disorder—Zoledronate—Paget's disease of bone	0.00524	0.00524	CcSEcCtD
Oritavancin—Mediastinal disorder—Zoledronate—Paget's disease of bone	0.00523	0.00523	CcSEcCtD
Oritavancin—Hypersensitivity—Etidronic acid—Paget's disease of bone	0.00512	0.00512	CcSEcCtD
Oritavancin—Anaemia—Pamidronate—Paget's disease of bone	0.00511	0.00511	CcSEcCtD
Oritavancin—Angioedema—Pamidronate—Paget's disease of bone	0.00506	0.00506	CcSEcCtD
Oritavancin—Malnutrition—Zoledronate—Paget's disease of bone	0.00505	0.00505	CcSEcCtD
Oritavancin—Myalgia—Risedronate—Paget's disease of bone	0.00496	0.00496	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.00492	0.00492	CcSEcCtD
Oritavancin—Pruritus—Etidronic acid—Paget's disease of bone	0.00492	0.00492	CcSEcCtD
Oritavancin—Diarrhoea—Etidronic acid—Paget's disease of bone	0.00475	0.00475	CcSEcCtD
Oritavancin—Infection—Risedronate—Paget's disease of bone	0.00472	0.00472	CcSEcCtD
Oritavancin—Myalgia—Pamidronate—Paget's disease of bone	0.00471	0.00471	CcSEcCtD
Oritavancin—Urticaria—Alendronate—Paget's disease of bone	0.0047	0.0047	CcSEcCtD
Oritavancin—Anaemia—Zoledronate—Paget's disease of bone	0.00467	0.00467	CcSEcCtD
Oritavancin—Nervous system disorder—Risedronate—Paget's disease of bone	0.00466	0.00466	CcSEcCtD
Oritavancin—Angioedema—Zoledronate—Paget's disease of bone	0.00462	0.00462	CcSEcCtD
Oritavancin—Skin disorder—Risedronate—Paget's disease of bone	0.00461	0.00461	CcSEcCtD
Oritavancin—Infection—Pamidronate—Paget's disease of bone	0.00449	0.00449	CcSEcCtD
Oritavancin—Nervous system disorder—Pamidronate—Paget's disease of bone	0.00443	0.00443	CcSEcCtD
Oritavancin—Vomiting—Etidronic acid—Paget's disease of bone	0.00442	0.00442	CcSEcCtD
Oritavancin—Tachycardia—Pamidronate—Paget's disease of bone	0.00441	0.00441	CcSEcCtD
Oritavancin—Rash—Etidronic acid—Paget's disease of bone	0.00438	0.00438	CcSEcCtD
Oritavancin—Dermatitis—Etidronic acid—Paget's disease of bone	0.00438	0.00438	CcSEcCtD
Oritavancin—Hypersensitivity—Alendronate—Paget's disease of bone	0.00436	0.00436	CcSEcCtD
Oritavancin—Headache—Etidronic acid—Paget's disease of bone	0.00435	0.00435	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Risedronate—Paget's disease of bone	0.00433	0.00433	CcSEcCtD
Oritavancin—Myalgia—Zoledronate—Paget's disease of bone	0.0043	0.0043	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.00427	0.00427	CcSEcCtD
Oritavancin—Pruritus—Alendronate—Paget's disease of bone	0.00419	0.00419	CcSEcCtD
Oritavancin—Nausea—Etidronic acid—Paget's disease of bone	0.00413	0.00413	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Pamidronate—Paget's disease of bone	0.00411	0.00411	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.0041	0.0041	CcSEcCtD
Oritavancin—Infection—Zoledronate—Paget's disease of bone	0.0041	0.0041	CcSEcCtD
Oritavancin—Diarrhoea—Alendronate—Paget's disease of bone	0.00405	0.00405	CcSEcCtD
Oritavancin—Nervous system disorder—Zoledronate—Paget's disease of bone	0.00405	0.00405	CcSEcCtD
Oritavancin—Tachycardia—Zoledronate—Paget's disease of bone	0.00403	0.00403	CcSEcCtD
Oritavancin—Skin disorder—Zoledronate—Paget's disease of bone	0.00401	0.00401	CcSEcCtD
Oritavancin—Dizziness—Alendronate—Paget's disease of bone	0.00392	0.00392	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.0039	0.0039	CcSEcCtD
Oritavancin—Urticaria—Risedronate—Paget's disease of bone	0.00377	0.00377	CcSEcCtD
Oritavancin—Vomiting—Alendronate—Paget's disease of bone	0.00376	0.00376	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Zoledronate—Paget's disease of bone	0.00376	0.00376	CcSEcCtD
Oritavancin—Rash—Alendronate—Paget's disease of bone	0.00373	0.00373	CcSEcCtD
Oritavancin—Dermatitis—Alendronate—Paget's disease of bone	0.00373	0.00373	CcSEcCtD
Oritavancin—Headache—Alendronate—Paget's disease of bone	0.00371	0.00371	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.00356	0.00356	CcSEcCtD
Oritavancin—Nausea—Alendronate—Paget's disease of bone	0.00352	0.00352	CcSEcCtD
Oritavancin—Hypersensitivity—Risedronate—Paget's disease of bone	0.0035	0.0035	CcSEcCtD
Oritavancin—Pruritus—Risedronate—Paget's disease of bone	0.00336	0.00336	CcSEcCtD
Oritavancin—Hypersensitivity—Pamidronate—Paget's disease of bone	0.00333	0.00333	CcSEcCtD
Oritavancin—Urticaria—Zoledronate—Paget's disease of bone	0.00328	0.00328	CcSEcCtD
Oritavancin—Diarrhoea—Risedronate—Paget's disease of bone	0.00325	0.00325	CcSEcCtD
Oritavancin—Pruritus—Pamidronate—Paget's disease of bone	0.00319	0.00319	CcSEcCtD
Oritavancin—Dizziness—Risedronate—Paget's disease of bone	0.00314	0.00314	CcSEcCtD
Oritavancin—Diarrhoea—Pamidronate—Paget's disease of bone	0.00309	0.00309	CcSEcCtD
Oritavancin—Hypersensitivity—Zoledronate—Paget's disease of bone	0.00304	0.00304	CcSEcCtD
Oritavancin—Vomiting—Risedronate—Paget's disease of bone	0.00302	0.00302	CcSEcCtD
Oritavancin—Rash—Risedronate—Paget's disease of bone	0.003	0.003	CcSEcCtD
Oritavancin—Dermatitis—Risedronate—Paget's disease of bone	0.00299	0.00299	CcSEcCtD
Oritavancin—Dizziness—Pamidronate—Paget's disease of bone	0.00299	0.00299	CcSEcCtD
Oritavancin—Headache—Risedronate—Paget's disease of bone	0.00298	0.00298	CcSEcCtD
Oritavancin—Pruritus—Zoledronate—Paget's disease of bone	0.00292	0.00292	CcSEcCtD
Oritavancin—Vomiting—Pamidronate—Paget's disease of bone	0.00287	0.00287	CcSEcCtD
Oritavancin—Rash—Pamidronate—Paget's disease of bone	0.00285	0.00285	CcSEcCtD
Oritavancin—Dermatitis—Pamidronate—Paget's disease of bone	0.00284	0.00284	CcSEcCtD
Oritavancin—Headache—Pamidronate—Paget's disease of bone	0.00283	0.00283	CcSEcCtD
Oritavancin—Diarrhoea—Zoledronate—Paget's disease of bone	0.00282	0.00282	CcSEcCtD
Oritavancin—Nausea—Risedronate—Paget's disease of bone	0.00282	0.00282	CcSEcCtD
Oritavancin—Dizziness—Zoledronate—Paget's disease of bone	0.00273	0.00273	CcSEcCtD
Oritavancin—Nausea—Pamidronate—Paget's disease of bone	0.00268	0.00268	CcSEcCtD
Oritavancin—Vomiting—Zoledronate—Paget's disease of bone	0.00262	0.00262	CcSEcCtD
Oritavancin—Rash—Zoledronate—Paget's disease of bone	0.0026	0.0026	CcSEcCtD
Oritavancin—Dermatitis—Zoledronate—Paget's disease of bone	0.0026	0.0026	CcSEcCtD
Oritavancin—Headache—Zoledronate—Paget's disease of bone	0.00258	0.00258	CcSEcCtD
Oritavancin—Nausea—Zoledronate—Paget's disease of bone	0.00245	0.00245	CcSEcCtD
